These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28840637)

  • 41. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
    Konda T; Enomoto A; Matsushita J; Takahara A; Moriyama T
    Nephron Physiol; 2005; 101(1):p1-13. PubMed ID: 15886499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension.
    Hamada T; Yamada K; Mizuta E; Watanabe A; Osaki T; Ishida K; Hasegawa A; Sakata S; Mishima M; Ogino K; Nosaka Y; Miyazaki S; Ohtahara A; Ninomiya H; Kato M; Yoshida A; Taniguchi S; Yamamoto K; Hisatome I
    Clin Exp Hypertens; 2012; 34(7):470-3. PubMed ID: 22681507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
    Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
    Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and rationale of Japanese evaluation between Formula of Azelnidipine and amlodipine add on olmesartan to Get antialbuminuric effect study (J-FLAG) : evaluation of the antialbuminuric effects between calcium channel blocker with sympatholytic action in hypertensive patients with diabetes and albuminuria.
    Ando K; Haneda M; Ito S; Kashihara N; Node K; Nangaku M; Shimosawa T; Kishimoto J; Fujita T
    Cardiovasc Drugs Ther; 2011 Aug; 25(4):341-7. PubMed ID: 21637969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
    Konoshita T; Makino Y; Kimura T; Fujii M; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
    J Hypertens; 2010 Oct; 28(10):2156-60. PubMed ID: 20625317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
    Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
    Hypertens Res; 2011 Feb; 34(2):268-73. PubMed ID: 21124330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.
    Viberti G; Wheeldon NM;
    Circulation; 2002 Aug; 106(6):672-8. PubMed ID: 12163426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Open Label Prospective Study on Evaluation of Safety and Efficacy of Cilnidipine Over Amlodipine in Stage 1 Hypertensive Patients.
    Harlalka S; Roy UK; Majumdar G; Das K; Mandal P
    Kathmandu Univ Med J (KUMJ); 2020 Jan.-Mar; 18(69):42-48. PubMed ID: 33582687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine.
    Saiz Satjes M; Martinez-Martin FJ
    Future Cardiol; 2016 Jul; 12(4):435-47. PubMed ID: 27221471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
    Takatsu M; Hattori T; Murase T; Ohtake M; Kato M; Nashima K; Nakashima C; Takahashi K; Ito H; Niinuma K; Aritomi S; Murohara T; Nagata K
    J Hypertens; 2012 Sep; 30(9):1845-55. PubMed ID: 22796710
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy.
    Fujisawa T; Ikegami H; Noso S; Hiromine Y; Kawabata Y; Nishino M; Asano K; Ogihara T
    J Diabetes Complications; 2007; 21(4):252-7. PubMed ID: 17616356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.
    Nakatsu T; Toyonaga S; Mashima K; Yuki Y; Nishitani A; Ogawa H; Miyoshi T; Hirohata S; Izumi R; Kusachi S
    Clin Drug Investig; 2010; 30(10):699-706. PubMed ID: 20701401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albuminuria in diabetes mellitus: relation to ambulatory versus office blood pressure and effects of cilazapril.
    Waeber B; Weidmann P; Wohler D; Le Bloch Y
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1220-7. PubMed ID: 8972894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cilnidipine: Next Generation Calcium Channel Blocker.
    Shete MM
    J Assoc Physicians India; 2016 Apr; 64(4):95-99. PubMed ID: 27734656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
    Bakris GL; Smith AC; Richardson DJ; Hung E; Preston R; Goldberg R; Epstein M
    J Hum Hypertens; 2002 Mar; 16(3):185-91. PubMed ID: 11896508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, 'real-world' comparison with amlodipine.
    Ohta M; Sugawara S; Sato N; Kuriyama C; Hoshino C; Kikuchi A
    Clin Drug Investig; 2009; 29(11):739-46. PubMed ID: 19813777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria.
    Fogari R; Mugellini A; Zoppi A; Lazzari P; Destro M; Rinaldi A; Preti P
    Eur J Clin Pharmacol; 2005 Aug; 61(7):483-90. PubMed ID: 16021438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.